Bollard Group LLC raised its stake in AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) by 0.4% during the second quarter, according to its most recent filing with the SEC. The firm owned 2,924 shares of the company’s stock after buying an additional 12 shares during the period. Bollard Group LLC’s holdings in AmerisourceBergen Corporation (Holding Co) were worth $276,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also modified their holdings of the company. Koshinski Asset Management Inc. boosted its stake in AmerisourceBergen Corporation (Holding Co) by 101.9% in the first quarter. Koshinski Asset Management Inc. now owns 5,509 shares of the company’s stock worth $488,000 after buying an additional 2,780 shares in the last quarter. Creative Planning boosted its stake in AmerisourceBergen Corporation (Holding Co) by 3.6% in the first quarter. Creative Planning now owns 19,042 shares of the company’s stock worth $1,685,000 after buying an additional 658 shares in the last quarter. Raymond James Trust N.A. boosted its stake in AmerisourceBergen Corporation (Holding Co) by 4.2% in the first quarter. Raymond James Trust N.A. now owns 3,594 shares of the company’s stock worth $318,000 after buying an additional 145 shares in the last quarter. Osborn Williams & Donohoe LLC boosted its stake in AmerisourceBergen Corporation (Holding Co) by 3.1% in the first quarter. Osborn Williams & Donohoe LLC now owns 9,016 shares of the company’s stock worth $798,000 after buying an additional 271 shares in the last quarter. Finally, Hefty Wealth Partners purchased a new stake in AmerisourceBergen Corporation (Holding Co) during the first quarter worth $1,072,000. Institutional investors own 68.87% of the company’s stock.
AmerisourceBergen Corporation (NYSE ABC) opened at 80.33 on Wednesday. AmerisourceBergen Corporation has a 52-week low of $68.38 and a 52-week high of $97.85. The stock has a market capitalization of $17.54 billion, a price-to-earnings ratio of 15.59 and a beta of 0.91. The firm’s 50-day moving average is $92.96 and its 200-day moving average is $89.37.
AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) last released its quarterly earnings results on Thursday, August 3rd. The company reported $1.43 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.37 by $0.06. AmerisourceBergen Corporation (Holding Co) had a return on equity of 56.07% and a net margin of 0.56%. The business had revenue of $38.71 billion during the quarter, compared to analysts’ expectations of $39.13 billion. During the same quarter in the prior year, the business earned $1.37 earnings per share. The company’s quarterly revenue was up 4.9% compared to the same quarter last year. Analysts predict that AmerisourceBergen Corporation will post $5.88 earnings per share for the current year.
Several equities analysts recently commented on ABC shares. Zacks Investment Research lowered shares of AmerisourceBergen Corporation (Holding Co) from a “hold” rating to a “sell” rating in a research report on Monday, July 10th. Vetr raised shares of AmerisourceBergen Corporation (Holding Co) from a “hold” rating to a “buy” rating and set a $92.52 price objective for the company in a research report on Tuesday, April 11th. Jefferies Group LLC started coverage on shares of AmerisourceBergen Corporation (Holding Co) in a research report on Wednesday, May 17th. They issued a “hold” rating and a $95.00 price objective for the company. Mizuho increased their price objective on shares of AmerisourceBergen Corporation (Holding Co) from $83.00 to $93.00 and gave the company a “neutral” rating in a research report on Tuesday, May 30th. Finally, Bank of America Corporation lowered shares of AmerisourceBergen Corporation (Holding Co) from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $95.76 to $94.00 in a research report on Friday, June 30th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $93.14.
In other news, Chairman Steven H. Collis sold 15,000 shares of the company’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $94.76, for a total transaction of $1,421,400.00. Following the completion of the sale, the chairman now owns 253,876 shares in the company, valued at $24,057,289.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 27.40% of the stock is owned by corporate insiders.
About AmerisourceBergen Corporation (Holding Co)
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Corporation (Holding Co) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corporation (Holding Co) and related companies with MarketBeat.com's FREE daily email newsletter.
